These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 16447288)

  • 1. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of simple noninvasive markers of liver fibrosis in qualification to treatment in patients with chronic hepatitis C].
    Gietka JA
    Przegl Epidemiol; 2011; 65(1):27-34. PubMed ID: 21735832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive monitoring of patients with chronic hepatitis C.
    Fontana RJ; Lok AS
    Hepatology; 2002 Nov; 36(5 Suppl 1):S57-64. PubMed ID: 12407577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology.
    Verveer C; de Knegt RJ
    Scand J Gastroenterol Suppl; 2006; (243):85-8. PubMed ID: 16782627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis.
    Sène D; Limal N; Messous D; Ghillani-Dalbin P; Charlotte F; Thiollière JM; Piette JC; Imbert-Bismut F; Halfon P; Poynard T; Cacoub P
    Clin Biochem; 2006 Jul; 39(7):715-21. PubMed ID: 16765932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?
    Mardini H; Record C
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):441-7. PubMed ID: 16259794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
    Sebastiani G; Alberti A
    J Viral Hepat; 2012 Jan; 19 Suppl 1():18-32. PubMed ID: 22233410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fibrosis in chronic liver diseases.
    Zhou K; Lu LG
    J Dig Dis; 2009 Feb; 10(1):7-14. PubMed ID: 19236541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive biomarkers of liver fibrosis in liver transplant patients with hepatitis C: can we avoid liver biopsies?
    Berenguer M
    Dig Liver Dis; 2009 Mar; 41(3):226-8. PubMed ID: 19138576
    [No Abstract]   [Full Text] [Related]  

  • 18. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.
    Castera L
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):291-303. PubMed ID: 21497746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and quantitation of fibrosis.
    Manning DS; Afdhal NH
    Gastroenterology; 2008 May; 134(6):1670-81. PubMed ID: 18471546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical and histopathologic perspective on evolving noninvasive and invasive alternatives for liver biopsy.
    Van Leeuwen DJ; Balabaud C; Crawford JM; Bioulac-Sage P; Dhillon AP
    Clin Gastroenterol Hepatol; 2008 May; 6(5):491-6. PubMed ID: 18455694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.